@iasociety @_IAS2013 @CrowdOutAIDS IAS 2013: #Innovations in #HIV #Testing, #Cure and #Care The world’s largest open scientific conference on HIV/AIDS – the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) will be held in Kuala Lumpur, Malaysia from 30 June-3 July 2013. Held every two years, the conference, which is one of the world´s leading open HIV scientific forums, provides a unique opportunity for the world’s leading scientists, clinicians, public health experts and community leaders to examine the latest developments in HIV-related research, and to explore how scientific advances can be translated quickly into effective interventions to prevent and treat HIV, particularly in low and middle-income countries. This year the conference aims to focus upon strategies for pursuing an HIV cure; the impact of starting antiretroviral therapy at higher CD4 counts; and innovative models for HIV testing and care. “Functional cures” and the benefits of early antiretroviral therapeutic treatment have been attracting international attention since researchers at the IAS 2011 conference announced that the HPTN 052 trial determined that starting early antiretroviral therapy (ART), regardless of CD4 count, rather than waiting for the CD4 count to fall to 250 lowered the risk of HIV transmission in HIV-discordant couples by 96%. Thus Treatment as Prevention (TasP) was formally born. Over the past two years there has been considerable research undertaken on the benefits of early antiretroviral therapeutic treatment in addition to the implementation aspects of TasP. The main objectives of IAS 2013 conference are to: *Highlight the state of the HIV epidemic and the progresses made in HIV research and prevention in the Asia-Pacific region *Focus on the latest biomedical HIV science for clinical practice and prevention *Provide new insights into HIV vulnerability, disease progression and prevention interventions *Review implementation science research by scaling up research and prevention especially in resource limited/ policy constraint environments *Provide opportunities for professional development, scientific collaboration, debate and dialogue among HIV professionals *Increase public awareness of the impact of HIV and AIDS with a focus on the implications of new scientific research on the global response *Advocate for keeping the HIV issue on top of the global agenda
Posted on: Mon, 17 Jun 2013 16:45:00 +0000
Trending Topics
Recently Viewed Topics
© 2015